1. Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer
   Alejandra Martinez et al, 2020, Cancers CrossRef
2. Variable roles of interleukin-17F in different cancers
   Tiina Mikkola et al, 2022, BMC Cancer CrossRef
3. Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma
   Sofya Marchenko et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
4. An association of circulating Tregs and Th17 cells producing IL-21 and IL-22 with the ROMA in ovarian cancer patients
   Izabela Winkler et al, 2020, Cytokine CrossRef
5. An association of iNKT+/CD3+/CD161+ lymphocytes in ovarian cancer tissue with CA125 serum concentration
   Izabela Winkler et al, 2020, Immunobiology CrossRef
6. HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression
   Rachael B. Rowswell-Turner et al, 2021, The Journal of Immunology CrossRef
7. The Role of Exosomes in Cancer Progression
   Beáta Soltész et al, 2021, International Journal of Molecular Sciences CrossRef
8. Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy
   Monika Bilska et al, 2020, Journal of Oncology CrossRef
9. The potential role of interleukins and interferons in ovarian cancer
   Huldani Huldani et al, 2023, Cytokine CrossRef
10. Potential tools for predicting response to chemotherapy in OC: Assessment of immune dysbiosis, participant’s self-rated health and microbial dynamics
    Taylor Badger et al, 2024, Journal of Reproductive Immunology CrossRef